Weijun Fu

5PUBLICATIONS
47CO-AUTHORS
Medical infection agents (incl. prions)Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2024
Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis.

Hua Jiang, Lu Li, Meiyu Guo

|Feb 03, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial.

Tingyu Wang, Xiuhua Sun, Lihua Qiu

|Oct 21, 2022
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1).

Jian-Qing Mi, Wanhong Zhao, Hongmei Jing

|Sep 21, 2022
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials.

Bruno Paiva, Irene Manrique, Meletios A Dimopoulos

Pageof 1

Frequent Collaborators

1 joint publications

Xiaoxia Hu

1 joint publications

Kihyun Kim

1 joint publications

Chunyang Zhang

1 joint publications

Cheolwon Suh